ルベル・インターナショナル病院
| トルコ | オーストリア | スペイン | |
| 肝動脈化学塞栓療法 | から $7,500 | から $16,000 | から $12,000 |
| 肝切除術 | から $11,700 | から $35,000 | から $35,000 |
| 肝ラジオ波焼灼術 | から $3,500 | から $12,000 | から $8,500 |
| 肝がん切除術 | から $10,800 | から $40,000 | から $35,000 |
| 肝臓癌の化学療法 | から $1,800 | - | から $571 |
Jaume Capdevila医師は、Centro Médico Teknonにて進行がん症例を専門とし、腫瘍患者に対して1,100件以上の治療を実施してきました。
この医師は腹膜癌症に特化した腫瘍外科医であり、2019年からTeknon Oncology InstituteのCarcinomatosis Surgical Groupの一員です。彼女はワシントン病院センターでPaul Sugarbaker教授の下で専門を修了し、American Board of Surgeryの認定を受けています。<\/p>
彼女はAmerican College of SurgeonsやSociety of Surgical Oncologyなどのいくつかの著名な学会のメンバーです。彼女の学術的な役割には、Inova Fairfax Hospitalの研究ディレクターや、Virginia Commonwealth UniversityおよびGeorgetown Universityでの准教授職が含まれています。<\/p>
Dr. Agusti Barnadas Molins is the chief breast cancer specialist at Teknon Oncology Institute in Barcelona. He has directed more than 70 research projects on breast cancer and gynecological oncology. Dr. Barnadas Molins treats tumors using chemotherapy, gland therapy, and immunotherapy. He practices at JCI-accredited Centro Médico Teknon.
Spanish centers offer advanced surgical techniques for unresectable liver metastases including ALPPS, two-stage hepatectomies, and histotripsy. These protocols focus on rapid liver regeneration and non-thermal tumor destruction. Specialist teams in Madrid and Barcelona utilize intraoperative navigation to preserve healthy parenchymal tissue during resection.
Bookimed Expert Insight: Spain is a global leader in high-volume hepatobiliary care, with centers like Centro Médico Teknon performing 23,500 operations annually. Data shows that Spanish specialists like Dr. Lana Bijelic often combine resection with intraoperative ablation. This allows treatment of multiple nodules that would typically be deemed unresectable elsewhere. Choosing centers with multidisciplinary liver boards ensures access to these combined-modality protocols.
Patient Consensus: Patients often find that seeking a second opinion at high-volume Spanish centers is vital. They note that what one hospital labels unresectable may be eligible for staged surgery or ablation-assisted resection.
Spanish medical centers offer non-surgical local therapies including percutaneous ablation, transarterial procedures, and targeted radiation. These treatments destroy liver tumors without major surgery. Options like radiofrequency ablation (RFA) and chemoembolization are available at JCI-accredited facilities in Madrid and Barcelona.
Bookimed Expert Insight: Spanish oncology centers like Centro Médico Teknon and Hospital Ruber Internacional stand out due to their high patient volumes and JCI accreditation. Data shows these facilities manage over 10,000 cases annually. This volume correlates with deep expertise in managing complex oligometastatic liver disease through multidisciplinary tumor boards.
Patient Consensus: Patients note it's important to confirm if a center has on-site interventional radiology. Many emphasize requesting a multidisciplinary review to choose between ablation and SIRT.
Patients can access pioneering clinical trials for liver metastases in Spain. The country is a leading European oncology research hub. Specialized trials focus on molecular profiling and liver-directed therapies. Leading centers like Quironsalud Madrid and Hospital Universitario HM Sanchinarro authorize numerous clinical studies yearly.
Bookimed Expert Insight: Spain’s clinical trial landscape allows for unique opportunities where treatment costs might be fully covered for eligible participants. At Quironsalud Madrid, our data shows patients can potentially access therapy for free if they meet strict study criteria. This is particularly valuable for liver metastases where traditional treatment costs can rise quickly.
Patient Consensus: Patients note that having a doctor who understands the trial network is vital for successful entry. They emphasize that specific tumor markers often determine if you qualify for the most advanced research pathways.
Spain hosts several JCI-accredited facilities specializing in liver metastasis, including Centro Médico Teknon in Barcelona and Clinica Universidad de Navarra in Pamplona. These centers utilize multidisciplinary teams to provide liver resection, radiofrequency ablation, and chemoembolization. Leading specialists like Dr. Jaume Capdevila coordinate complex oncology care.
Bookimed Expert Insight: Patient volume indicates that high-capacity centers like Hospital HM Nou Delfos treat 400,000 patients annually. This massive scale often correlates with faster diagnostic turnaround for complex cases. Large multi-center groups like HM Hospitales ensure specialized oncology teams are available across their 7 integrated facilities.
Patient Consensus: Patients emphasize that multidisciplinary reviews are vital. It is common to travel to Madrid or Barcelona for evaluation at high-volume liver units.
Spanish oncologists stage liver metastases by combining high-resolution triple-phase CT or contrast-enhanced MRI with mandatory genomic profiling. They categorize cases into resectable, borderline, or unresectable phenotypes. Treatment plans are designed by multidisciplinary tumor boards to ensure personalized, multimodal care for every patient.
Bookimed Expert Insight: Spanish centers like Clinica Universidad de Navarra and Centro Médico Teknon provide a distinct advantage through high patient volumes. Clinica Universidad de Navarra treats over 140,000 patients from 70 countries annually. This vast experience allows their multidisciplinary boards to manage complex cases that smaller centers might deem untreatable.
Patient Consensus: Patients note that staging involves the entire disease picture rather than just liver scans. They emphasize that initial unresectability can change, as chemotherapy often shrinks tumors enough to allow for later surgery.